These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


427 related items for PubMed ID: 27647569

  • 1. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
    Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD, Walters RR, Dunham SA.
    Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
    [Abstract] [Full Text] [Related]

  • 2. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.
    Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD, Martinon OM.
    Vet Dermatol; 2016 Dec; 27(6):505-e136. PubMed ID: 27647513
    [Abstract] [Full Text] [Related]

  • 3. A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.
    Moyaert H, Van Brussel L, Borowski S, Escalada M, Mahabir SP, Walters RR, Stegemann MR.
    Vet Dermatol; 2017 Dec; 28(6):593-e145. PubMed ID: 28906040
    [Abstract] [Full Text] [Related]

  • 4. Correlation between clinical efficacy on pruritus and serum interleukin-31 levels in dogs with atopic dermatitis treated with lokivetmab.
    Calesso JR, Marques VS, de Carvalho OV, Costa-Val AP.
    Pol J Vet Sci; 2023 Jun; 26(2):231-238. PubMed ID: 37389418
    [Abstract] [Full Text] [Related]

  • 5. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
    Little PR, King VL, Davis KR, Cosgrove SB, Stegemann MR.
    Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
    [Abstract] [Full Text] [Related]

  • 6. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
    Cosgrove SB, Wren JA, Cleaver DM, Walsh KF, Follis SI, King VI, Tena JK, Stegemann MR.
    Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
    [Abstract] [Full Text] [Related]

  • 7. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA.
    Souza CP, Rosychuk RAW, Contreras ET, Schissler JR, Simpson AC.
    Vet Dermatol; 2018 Dec; 29(6):489-e164. PubMed ID: 30141223
    [Abstract] [Full Text] [Related]

  • 8. Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs.
    Marsella R, Ahrens K, Wilkes R, Trujillo A, Dorr M.
    Vet Dermatol; 2020 Aug; 31(4):284-e69. PubMed ID: 32301565
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Weekly topical therapy based on plant extracts combined with lokivetmab in canine atopic dermatitis.
    Bensignor E, Videmont E.
    Vet Dermatol; 2022 Feb; 33(1):68-e22. PubMed ID: 34414621
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.